| Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma RE Davis, VN Ngo, G Lenz, P Tolar, RM Young, PB Romesser, ... Nature 463 (7277), 88-92, 2010 | 1881 | 2010 |
| Oncogenically active MYD88 mutations in human lymphoma VN Ngo, RM Young, R Schmitz, S Jhavar, W Xiao, KH Lim, ... Nature 470 (7332), 115-119, 2011 | 1723 | 2011 |
| PD-1 blockade in mismatch repair–deficient, locally advanced rectal cancer A Cercek, M Lumish, J Sinopoli, J Weiss, J Shia, M Lamendola-Essel, ... New England Journal of Medicine 386 (25), 2363-2376, 2022 | 779 | 2022 |
| A rectal cancer organoid platform to study individual responses to chemoradiation K Ganesh, C Wu, KP O’Rourke, BC Szeglin, Y Zheng, CEG Sauvé, ... Nature medicine 25 (10), 1607-1614, 2019 | 367 | 2019 |
| NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination M Ruscetti, J Leibold, MJ Bott, M Fennell, A Kulick, NR Salgado, CC Chen, ... Science 362 (6421), 1416-1422, 2018 | 289 | 2018 |
| Senescence-induced vascular remodeling creates therapeutic vulnerabilities in pancreas cancer M Ruscetti, JP Morris, R Mezzadra, J Russell, J Leibold, PB Romesser, ... Cell 181 (2), 424-441. e21, 2020 | 251 | 2020 |
| IRF4: immunity. malignancy! therapy? AL Shaffer, NCT Emre, PB Romesser, LM Staudt Clinical Cancer Research 15 (9), 2954-2961, 2009 | 251 | 2009 |
| Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer KP O'Rourke, E Loizou, G Livshits, EM Schatoff, T Baslan, E Manchado, ... Nature biotechnology 35 (6), 577-582, 2017 | 218 | 2017 |
| The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy ZS Zumsteg, DE Spratt, PB Romesser, X Pei, Z Zhang, W Polkinghorn, ... European urology 67 (6), 1009-1016, 2015 | 202 | 2015 |
| Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral … PB Romesser, O Cahlon, E Scher, Y Zhou, SL Berry, A Rybkin, KM Sine, ... Radiotherapy and Oncology 118 (2), 286-292, 2016 | 189 | 2016 |
| Therapy-induced senescence: opportunities to improve anticancer therapy PG Prasanna, DE Citrin, J Hildesheim, MM Ahmed, S Venkatachalam, ... JNCI: Journal of the National Cancer Institute 113 (10), 1285-1298, 2021 | 186 | 2021 |
| Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines GV Denis, ME McComb, DV Faller, A Sinha, PB Romesser, CE Costello Journal of proteome research 5 (3), 502-511, 2006 | 185 | 2006 |
| Proton beam reirradiation for recurrent head and neck cancer: multi-institutional report on feasibility and early outcomes PB Romesser, O Cahlon, ED Scher, EB Hug, K Sine, C DeSelm, JL Fox, ... International Journal of Radiation Oncology* Biology* Physics 95 (1), 386-395, 2016 | 170 | 2016 |
| Proton therapy for head and neck cancer: expanding the therapeutic window JE Leeman, PB Romesser, Y Zhou, S McBride, N Riaz, E Sherman, ... The lancet oncology 18 (5), e254-e265, 2017 | 152 | 2017 |
| Association of ablative radiation therapy with survival among patients with inoperable pancreatic cancer M Reyngold, EM O’Reilly, AM Varghese, M Fiasconaro, M Zinovoy, ... JAMA oncology 7 (5), 735-738, 2021 | 127 | 2021 |
| Anatomical patterns of recurrence following biochemical relapse in the dose escalation era of external beam radiotherapy for prostate cancer ZS Zumsteg, DE Spratt, PB Romesser, X Pei, Z Zhang, M Kollmeier, ... The Journal of urology 194 (6), 1624-1630, 2015 | 86 | 2015 |
| Superior prognostic utility of gross and metabolic tumor volume compared to standardized uptake value using PET/CT in head and neck squamous cell carcinoma patients treated … PB Romesser, MM Qureshi, BA Shah, LT Chatburn, S Jalisi, AK Devaiah, ... Annals of nuclear medicine 26, 527-534, 2012 | 85 | 2012 |
| The canonical Wnt pathway drives macropinocytosis in cancer G Redelman-Sidi, A Binyamin, I Gaeta, W Palm, CB Thompson, ... Cancer research 78 (16), 4658-4670, 2018 | 84 | 2018 |
| External beam radiotherapy with or without concurrent chemotherapy in advanced or recurrent non‐anaplastic non‐medullary thyroid cancer PB Romesser, EJ Sherman, AR Shaha, M Lian, RJ Wong, M Sabra, ... Journal of surgical oncology 110 (4), 375-382, 2014 | 79 | 2014 |
| Phase II single-arm study of durvalumab and tremelimumab with concurrent radiotherapy in patients with mismatch repair–proficient metastatic colorectal cancer NH Segal, A Cercek, G Ku, AJ Wu, A Rimner, DN Khalil, D Reidy-Lagunes, ... Clinical Cancer Research 27 (8), 2200-2208, 2021 | 62 | 2021 |
Christopher H CraneMSKCCПотвърден имейл адрес: mskcc.org
